Home LiteratureArticle Details
PMID: 30266410 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas.

Genomics, proteomics & bioinformatics ·Vol. 16 ·No. 4 ·2018-00-00 ·Pages 269-275

Lian Q, Wang S, Zhang G, Wang D, Luo G, Tang J, Chen L, Gu J

Abstract

Hepatocellular carcinoma (HCC) is highly heterogeneous in nature and has been one of the most common cancer types worldwide. To ensure repeatability of identified gene expression patterns and comprehensively annotate the transcriptomes of HCC, we carefully curated 15 public HCC expression datasets that cover around 4000 clinical samples and developed the database HCCDB to serve as a one-stop online resource for exploring HCC gene expression with user-friendly interfaces. The global differential gene expression landscape of HCC was established by analyzing the consistently differentially expressed genes across multiple datasets. Moreover, a 4D metric was proposed to fully characterize the expression pattern of each gene by integrating data from The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx). To facilitate a comprehensive understanding of gene expression patterns in HCC, HCCDB also provides links to third-party databases on drug, proteomics, and literatures, and graphically displays the results from computational analyses, including differential expression analysis, tissue-specific and tumor-specific expression analysis, survival analysis, and co-expression analysis. HCCDB is freely accessible at http://lifeome.net/database/hccdb.

Keywords
Database Hepatocellular carcinoma Integrative analysis Meta-analysis Transcriptome
MeSH Terms
Carcinoma, Hepatocellular/genetics Databases, Genetic Gene Expression Profiling Gene Expression Regulation, Neoplastic Humans Liver Neoplasms/genetics
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Lian Qiuyu
MOE Key Laboratory of Bioinformatics, Beijing National Research Center for Information Science and Technology, Bioinformatics Division, Department of Automation, Tsinghua University, Beijing 100084, China.
Wang Shicheng
MOE Key Laboratory of Bioinformatics, Beijing National Research Center for Information Science and Technology, Bioinformatics Division, Department of Automation, Tsinghua University, Beijing 100084, China.
Zhang Guchao
MOE Key Laboratory of Bioinformatics, Beijing National Research Center for Information Science and Technology, Bioinformatics Division, Department of Automation, Tsinghua University, Beijing 100084, China.
Wang Dongfang
MOE Key Laboratory of Bioinformatics, Beijing National Research Center for Information Science and Technology, Bioinformatics Division, Department of Automation, Tsinghua University, Beijing 100084, China.
Luo Guijuan
International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, China.
Tang Jing
International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, China.
Chen Lei
International Co-operation Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, China. Electronic address: chenlei@smmu.edu.cn.
Gu Jin
MOE Key Laboratory of Bioinformatics, Beijing National Research Center for Information Science and Technology, Bioinformatics Division, Department of Automation, Tsinghua University, Beijing 100084, China. Electronic address: jgu@tsinghua.edu.cn.
References (36)
36 references, click to expand
  1. Recurrent chromosome alterations in hepatocellular carcinoma detected by comparative genomic hybridization.
    Genes Chromosomes Cancer. 2000 Oct;29(2):110-6 PMID: 10959090
  2. OncoDB.HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci.
    Nucleic Acids Res. 2007 Jan;35(Database issue):D727-31 PMID: 17098932
  3. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.
    Cancer Res. 2008 Mar 1;68(5):1451-61 PMID: 18316609
  4. Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes.
    Hum Mutat. 2009 Feb;30(2):E451-9 PMID: 19058223
  5. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.
    Cancer Res. 2009 Sep 15;69(18):7385-92 PMID: 19723656
  6. Hepatocellular carcinoma (HCC) and diagnostic significance of A-fetoprotein (AFP).
    J Ayub Med Coll Abbottabad. 2009 Jan-Mar;21(1):72-5 PMID: 20364746
  7. Hallmarks of cancer: the next generation.
    Cell. 2011 Mar 4;144(5):646-74 PMID: 21376230
  8. Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival.
    Gastroenterology. 2012 Apr;142(4):957-966.e12 PMID: 22202459
  9. Liverome: a curated database of liver cancer-related gene signatures with self-contained context information.
    BMC Genomics. 2011 Nov 30;12 Suppl 3:S3 PMID: 22369201
  10. The role of glypican-3 in regulating Wnt in hepatocellular carcinomas.
    Cancer Rep. 2011;1(1):14-19 PMID: 22563565
  11. Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma marker.
    PLoS One. 2013;8(3):e59459 PMID: 23527199
  12. Glypican-3 binds to Frizzled and plays a direct role in the stimulation of canonical Wnt signaling.
    J Cell Sci. 2014 Apr 1;127(Pt 7):1565-75 PMID: 24496449
  13. Dedifferentiation and reprogramming: origins of cancer stem cells.
    EMBO Rep. 2014 Mar;15(3):244-53 PMID: 24531722
  14. Aldoketoreductase family 1B10 (AKR1B10) as a biomarker to distinguish hepatocellular carcinoma from benign liver lesions.
    Hum Pathol. 2014 Apr;45(4):834-43 PMID: 24656094
  15. Non-invasive Analysis of Genomic Copy Number Variation in Patients with Hepatocellular Carcinoma by Next Generation DNA Sequencing.
    J Cancer. 2015 Jan 18;6(3):247-53 PMID: 25663942
  16. Genetic Landscape and Biomarkers of Hepatocellular Carcinoma.
    Gastroenterology. 2015 Oct;149(5):1226-1239.e4 PMID: 26099527
  17. The consensus molecular subtypes of colorectal cancer.
    Nat Med. 2015 Nov;21(11):1350-6 PMID: 26457759
  18. The Genotype-Tissue Expression (GTEx) Project.
    Biopreserv Biobank. 2015 Oct;13(5):307-8 PMID: 26484569
  19. Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution.
    Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6496-505 PMID: 26561581
  20. Emerging Roles of SPINK1 in Cancer.
    Clin Chem. 2016 Mar;62(3):449-57 PMID: 26656134
  21. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
    Gastroenterology. 2016 Apr;150(4):998-1008 PMID: 26752112
  22. Cell type-specific properties and environment shape tissue specificity of cancer genes.
    Sci Rep. 2016 Feb 09;6:20707 PMID: 26856619
  23. CoINcIDE: A framework for discovery of patient subtypes across multiple datasets.
    Genome Med. 2016 Mar 09;8(1):27 PMID: 26961683
  24. Integrative Genomic Analysis Identifies the Core Transcriptional Hallmarks of Human Hepatocellular Carcinoma.
    Cancer Res. 2016 Nov 1;76(21):6374-6381 PMID: 27634755
  25. Tissue-specific and convergent metabolic transformation of cancer correlates with metastatic potential and patient survival.
    Nat Commun. 2016 Oct 10;7:13041 PMID: 27721378
  26. Genome-wide DNA methylation analysis identifies candidate epigenetic markers and drivers of hepatocellular carcinoma.
    Brief Bioinform. 2018 Jan 1;19(1):101-108 PMID: 27760737
  27. GPC-3 in hepatocellular carcinoma: current perspectives.
    J Hepatocell Carcinoma. 2016 Nov 08;3:63-67 PMID: 27878117
  28. Proteome-Scale Investigation of Protein Allosteric Regulation Perturbed by Somatic Mutations in 7,000 Cancer Genomes.
    Am J Hum Genet. 2017 Jan 5;100(1):5-20 PMID: 27939638
  29. Recurrently deregulated lncRNAs in hepatocellular carcinoma.
    Nat Commun. 2017 Feb 13;8:14421 PMID: 28194035
  30. The spatial organization of intra-tumour heterogeneity and evolutionary trajectories of metastases in hepatocellular carcinoma.
    Nat Commun. 2017 Feb 27;8:4565 PMID: 28240289
  31. Tissue-specific tumorigenesis: context matters.
    Nat Rev Cancer. 2017 Apr;17(4):239-253 PMID: 28256574
  32. Tissue-Specific Signaling Networks Rewired by Major Somatic Mutations in Human Cancer Revealed by Proteome-Wide Discovery.
    Cancer Res. 2017 Jun 1;77(11):2810-2821 PMID: 28364002
  33. Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
    Med Res Rev. 2018 Mar;38(2):741-767 PMID: 28621802
  34. A pathology atlas of the human cancer transcriptome.
    Science. 2017 Aug 18;357(6352): PMID: 28818916
  35. Analysis of Genomes and Transcriptomes of Hepatocellular Carcinomas Identifies Mutations and Gene Expression Changes in the Transforming Growth Factor-β Pathway.
    Gastroenterology. 2018 Jan;154(1):195-210 PMID: 28918914
  36. TissGDB: tissue-specific gene database in cancer.
    Nucleic Acids Res. 2018 Jan 4;46(D1):D1031-D1038 PMID: 29036590
Article Info
Journal
Genomics, proteomics & bioinformatics
Abbr.
Genomics Proteomics Bioinformatics
ISSN
2210-3244
Published
2018-00-00
Epub
2018-00-25
Pages
269-275
Language
English
Region
China
NLM ID
101197608
PMCID
PMC6205074
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com